Making Vaccines Easy
For two hundred years vaccines have been administered by intramuscular injection. Vaxart’s oral pill vaccines may change everything.
Vaxart’s oral COVID-19 vaccine holds the promise of longer protection from infection, broader protection against virus variants, and a greater reduction in virus transmission than the first-generation injectable vaccines.
Our vaccine acts differently, by attacking invading pathogens in the places where they first enter the body: the mucosal areas, including the mouth, the nose and the gut. It triggers strong IgA and T-cell responses to repel and overwhelm the invading viral invaders.
Vaxart is now in global Phase II trials of this vaccine – the only company in the world to reach this stage with a COVID-19 vaccine pill.
Our COVID-19 vaccine pill is designed to be room temperature-stable so it can be distributed globally with wide public acceptance, minimal cost and maximum speed.